Expect a steady news flowFDA meeting early Nov - pharmacy partners. They are moving fwd with launch activities, wont be such a slow down in terms of revenue than first anticipated is my guess.
"In coming weeks, Botanix also plans to finalize arrangements with its pharmacy partners as well as
other service providers, that will ultimately comprise the commercial infrastructure required to
successfully launch Sofdra™ post approval."
Expect a steady news flow :-) FDA meeting early Nov - pharmacy...
-
- There are more pages in this discussion • 71 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
-0.010(2.63%) |
Mkt cap ! $669.7M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.5¢ | 36.0¢ | $2.749M | 7.463M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 479653 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 57229 | 1 |
View Market Depth
| Last trade - 15.41pm 19/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |